Sirolimus
Information about Sirolimus
Sirolimus Uses
Sirolimus is used for prevention of kidney transplant rejection.
How Sirolimus works
Sirolimus is an immunosuppressant. It works by suppressing your body’s immune response following transplant of an organ (eg. liver, kidney, heart). This helps your body to accept the new organ as if it were your own.
Common side effects of Sirolimus
Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth), Sepsis, Kidney infection, Cytomegalovirus infection, Herpes zoster, Non-melanoma skin cancer, Hemolytic uremic syndrome, Hypersensitivity, Pericardial effusion, Venous thrombosis, Pulmonary embolism, Pneumonitis, Pleural effusion, Nosebleeds, Pancreatic inflammation, Ascites (accumulation of fluid in the abdominal cavity), Osteonecrosis (reduced blood flow to the bones), Ovarian cysts
Available Medicine for Sirolimus
SiromusZydus Cadila
₹10611 variant(s)
SiropanPanacea Biotec Pharma Ltd
₹23031 variant(s)
RocasEmcure Pharmaceuticals Ltd
₹7681 variant(s)
RapacanEris Lifesciences Ltd
₹2590 to ₹27732 variant(s)
SirovaIntas Pharmaceuticals Ltd
₹19501 variant(s)
RaparenLa Renon Healthcare Pvt Ltd
₹1499 to ₹15742 variant(s)
LimusClaris Lifesciences Ltd
₹13651 variant(s)
SiroglobGlobela Pharma Pvt Ltd
₹711 variant(s)
SirotrendAnthem Biopharma
₹15001 variant(s)
SiroboonKachhela Medex Pvt Ltd
₹1490 to ₹17902 variant(s)
Expert advice for Sirolimus
- You may be frequently monitored for renal function during concomitant administration of sirolimus and ciclosporin.
- Sirolimus increase risk of infection and the risk of developing certain types of cancer (e.g., lymphoma, skin cancer). Seek immediate medical attention if you notice signs of infection (e.g., persistent sore throat, chills, and fever), any changes in the appearance or size of a mole, night sweats, unusual growths or lumps, or unusual tiredness or weakness.
- Avoid use of live vaccines during treatment as the vaccination may be less effective when taking sirolimus.
- Use effective methods of contraception during sirolimus therapy and for 12 weeks after sirolimus has been stopped.
- Consult your doctor if you develop any liver problems, kidney problems, high cholesterol or triglycerides, low blood platelet levels, diabetes or high blood sugar, or lung or breathing problems or if you are considered to be at high risk for rejection, such as if you had a previous transplant that was lost to rejection.
- Limit the exposure to sunlight and UV light by covering your skin with clothing and using a sunscreen with a high protection factor because of the increased risk for skin cancer, when receiving sirolimus.
- Take sirolimus at the same time in relation to ciclosporin, and consistently with or without food, as its blood levels will be monitored.